Aleglitazar, a new, potent, and balanced dual PPARα/γ agonist for the treatment of type II diabetes
Authors:
- Jörg BenzJBJörg Benz
- Alfred BinggeliABAlfred Binggeli
- Denise BlumDBDenise Blum
- Markus BoehringerMBMarkus Boehringer
- Uwe GretherUGUwe Grether
- Hans HilpertHHHans Hilpert
- Bernd KuhnBKBernd Kuhn
- Hans Peter MärkiHMHans Peter Märki
- Markus MeyerMMMarkus Meyer
- Kurt PüntenerKPKurt Püntener
- Susanne RaabSRSusanne Raab
- 1 May 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (9) , 2468-2473
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- PPAR‐alpha: therapeutic role in diabetes‐related cardiovascular diseaseDiabetes, Obesity and Metabolism, 2008
- Effect of tesaglitazar, a dual PPARα/γ agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12‐week dose-ranging trialCurrent Medical Research and Opinion, 2006
- Structure-based design of indole propionic acids as novel PPARα/γ co-agonistsBioorganic & Medicinal Chemistry Letters, 2006
- Improvement of Glycemic Control, Triglycerides, and HDL Cholesterol Levels With Muraglitazar, a Dual (α/γ) Peroxisome Proliferator–Activated Receptor Activator, in Patients With Type 2 Diabetes Inadequately Controlled With Metformin MonotherapyDiabetes Care, 2006
- From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functionsProgress in Lipid Research, 2006
- Genomic Analysis of the Nuclear Receptor Family: New Insights Into Structure, Regulation, and Evolution From the Rat GenomeGenome Research, 2004
- Binding of Ligands and Activation of Transcription by Nuclear ReceptorsAnnual Review of Biophysics, 2001
- NEW AND CONVENIENT SYNTHESIS OF (R) AND (S) OF 2-METHYL-3-OXA-5-(TERT-BUTYLDIPHENYLSILYLOXYL) METHYLPENTANOATE AND 2-METHYL-3-OXA-5- (TERT-BUTYLDIMETHYLSILYLOXYL)METHYLPENTANOATEPhosphorus, Sulfur, and Silicon and the Related Elements, 2000
- Non-thiazolidinedione antihyperglycaemic agents. Part 5: Asymmetric aldol synthesis of (S)-(−)-2-oxy-3-arylpropanoic acidsTetrahedron: Asymmetry, 1999
- Studies on Azole Compounds. III. Reactions of Oxazole N-Oxides with Phosphoryl Chloride and Acetic AnhydrideChemical and Pharmaceutical Bulletin, 1971